Vicryl
Vicryl is a medical device with 10 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 9 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
9 of 9 finished
0.0%
0 ended early
0
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Stratafix Vs. Vicryl OAGB / MGB Suture Study
Triclosan-antibacterial Sutures Efficacy on the Incidence of Surgical Site Infection in Clean-contaminated Wounds
The PLUS Study: Comparison of VicrylPlus® Versus Vicryl® for Repair of Perineal Tears
Evaluation of Triclosan Coated Suture in Obstetrical Surgery
The Use of STRATAFIX Suture Device Compared to Standard-of-care for Deep Tissue Closure in Total Knee Arthroplasty
Clinical Trials (10)
Stratafix Vs. Vicryl OAGB / MGB Suture Study
Triclosan-antibacterial Sutures Efficacy on the Incidence of Surgical Site Infection in Clean-contaminated Wounds
The PLUS Study: Comparison of VicrylPlus® Versus Vicryl® for Repair of Perineal Tears
Evaluation of Triclosan Coated Suture in Obstetrical Surgery
The Use of STRATAFIX Suture Device Compared to Standard-of-care for Deep Tissue Closure in Total Knee Arthroplasty
Prospective Randomized Trial of Stratafix vs. Vicryl in Total Hip Arthroplasty.
Comparison of Laparoscopic Traditional and Knotless Sutures
Compare Antimicrobial to Conventional Suture in Patients Receiving Primary Total Knee Replacement
The Impact of Using Triclosan-antibacterial Sutures on the Incidence of Surgical Site Infection
Oral Bacteria on Suture Materials - Clinical Comparison of an Antibacterial-coated and a Non-coated Suture Material
All 10 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 10